scispace - formally typeset
J

Jon Glass

Researcher at Thomas Jefferson University

Publications -  37
Citations -  1373

Jon Glass is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Temozolomide & Radiation therapy. The author has an hindex of 15, co-authored 30 publications receiving 1029 citations.

Papers
More filters
Journal ArticleDOI

Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas

TL;DR: H- SRT was well tolerated and resulted in a median survival time of 11 months after H-SRT, independent of re-operation or concomitant chemotherapy, in recurrent high-grade gliomas.
Journal ArticleDOI

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.

TL;DR: A KD appears safe and well tolerated during the standard treatment of GBM, and dietary restriction of carbohydrates through a KD reduces serum glucose levels significantly, even in conjunction with high dose steroids, which may affect the response to standard treatment and prognosis.
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.